longevity science
75% Cost Drop Longevity Science vs Animal‑Derived Hepatocytes
iPSC-derived hepatocytes can lower liver-cell therapy costs by up to 75% compared with traditional animal-derived cells, making personalized transplants far more affordable. The breakthrough stems from a new cryopreservation pipeline and modular bioreactor designs that deliver hundreds of patient-ready doses per run. 75% of the cost premium that once hampered